Results 81 to 90 of about 1,090 (156)

Sustainability of Teprotumumab Efficacy in Thyroid Eye Disease

open access: yes, 2022
Teprotumumab, an insulin-like growth factor-I receptor inhibitory antibody, improved proptosis, diplopia, inflammatory signs/symptoms, and quality of life in thyroid eye disease (TED) patients in phase 2 and 3 (OPTIC) trials.1,2 OPTIC proptosis non ...
Prem S. Subramanian; Saba Sile; Robert Holt; Raymond Douglas
core   +2 more sources

Morbidité et mortalité du protocole EUGOGO dans le cadre de la prise en charge de l'orbitopathie Basedowienne:thèse présentée pour le diplôme d'État de docteur en médecine, diplôme d'État, mention D.E.S endocrinologie, diabétologie et nutrition

open access: yes, 2022
Médecine (endocrinologie, diabétologie et nutrition)L'orbitopathie est la manifestation extra-thyroïdienne la plus fréquente de la maladie de Basedow, engageant le pronostic visuel. La corticothérapie lV est recommandée dans les formes modérées à sévères
Herfeld, Grégoire
core  

Graves ophthalmopathy a neglected comorbidity of graves’ disease; a detailed investigation and management of sixty-eight patients in a tertiary healthcare center

open access: yesBMC Endocrine Disorders
Purpose To compare the measurements of macular thickness, intraocular pressure and RNFL and hormone parameters before and after antithyroid therapy in patients with Graves’ Ophthalmopathy (GO).
Gamze Akkus   +6 more
doaj   +1 more source

Risk Factors for Ocular Surface Irritation Symptoms in Inactive Mild and Moderate-to-Severe Graves’ Orbitopathy

open access: yesOphthalmology and Therapy
Introduction This study aims to analyze risk factors for ocular surface irritation symptoms in patients with non-corneal-damage inactive mild and moderate-to-severe Graves’ orbitopathy (GO). Methods This retrospective study enrolled 307 patients with non-
Yun Yu   +6 more
doaj   +1 more source

Multidimensional predictive model for assessing clinical activity in thyroid eye disease

open access: yesFrontiers in Medicine
ObjectiveThyroid eye disease (TED) is an autoimmune disorder with complex inflammatory activity that remains challenging to assess accurately.
Yang Li   +22 more
doaj   +1 more source

Update on Graves’ ophthalmopathy

open access: yes, 2016
Trabalho Final do Curso de Mestrado Integrado em Medicina, Faculdade de Medicina, Universidade de Lisboa, 2016Oftalmopatia de Graves, doença ocular tiroideia ou orbitopatia tiroideia é uma patologia inflamatória autoimune que ocorre em aproximadamente 25%
Fernandes, Ana Sofia Cruz
core   +2 more sources

Determinants of clinical outcome in patients with moderate/severe Graves' orbitopathy undergoing treatment with parenteral glucocorticoids: a retrospective study

open access: yesFrontiers in Endocrinology
BackgroundGraves' orbitopathy (GO) occurs in approximately 25-40% of patients with Graves' disease (GD). High levels of anti-thyrotropin receptor antibodies (TRAbs), smoking habit, sex, older age, longer duration and amount of hyperthyroidism or ...
Rosario Le Moli   +9 more
doaj   +1 more source

Predictive score for the development or progression of Graves’ orbitopathy in patients with newly diagnosed Graves’ hyperthyroidism

open access: yes, 2018
OBJECTIVE : To construct a predictive score for the development or progression of Graves’ orbitopathy (GO) in Graves’ hyperthyroidism (GH). DESIGN : Prospective observational study in patients with newly diagnosed GH, treated with antithyroid drugs (ATD)
Töröner, F. sun Baloş   +106 more
core   +1 more source

ÜÇÜNCÜ BASAMAK REFERANS MERKEZİNE BAŞVURAN TİROİD ORBİTOPATİ OLGULARINDA KLİNİK BULGULAR VE TEDAVİ STRATEJİLERİ

open access: yes, 2008
Graves oftalmopatide (GO) izlenen semptom, klinik bulgu ve ölçülen parametrelerdeki çeşitlilik, olgularda tedavi ve takip zorluklarına yol açmaktadır. 2003 yılında EUGOGO tarafından GO olgularının değerlendirilmesinde standardizasyonu sağlamak amacıyla ...
MİNE ÖZTÜRK KURTULMUŞOĞLU
core   +2 more sources

Postępowanie w orbitopatii towarzyszącej chorobie Gravesa i Basedowa. Komentarz i uzupełnienie do stanowiska EUGOGO

open access: yesEndokrynologia Polska (Polish Journal of Endocrinology), 2009
Bednarczuk, Tomasz   +27 more
  +7 more sources

Home - About - Disclaimer - Privacy